Patients who have lesions w/ a propensity to bleed eg, ulcers, renal & hepatic impairment, at risk of increased bleeding from trauma, surgery or other pathological conditions or to undergo elective surgery. Hematopoietic disorders eg, neutropenia or thrombocytopenia, hemorrhagic diathesis or other hemorrhagic disorders. Pregnancy & lactation. Childn. Norplat-S
Perform full blood count prior to treatment, every 2 wk during 1st 3 mth of therapy & w/in 2 wk of discontinuing treatment. Allergy to ibuprofen or other NSAIDs; chronic or recurrent stomach or duodenal ulcers or digestive hemorrhages; severe renal impairment/disease & hepatic disease; allergic diseases eg, asthma or urticaria; gout. Patients at increased risk of bleeding from trauma, surgery or other pathological conditions. Discontinue use 5 days prior to elective surgery. Lesions which has a propensity to bleed eg, ulcers. Concomitant use w/ drugs that can induce lesions. Childn & adolescents w/ chickenpox, flu or fever.